糖尿病照护市场的临床营养、机会、成长动力、产业趋势分析与预测，2024-2032

由于全球糖尿病盛行率上升以及人们日益认识到饮食在控制病情方面的关键作用，糖尿病护理临床营养市场规模预计在 2024 年至 2032 年期间复合年增长率为 4.8%。根据世界卫生组织的数据，全球约有 4.22 亿人患有糖尿病。专为糖尿病照护设计的临床营养产品，例如低血糖指数食品、富含纤维的补充剂和营养丰富的代餐，有助于控制血糖水平并改善整体健康。

产品配方的进步以及根据个人代谢状况和健康状况制定量身定制的营养计划，正在增强饮食干预在糖尿病管理中的功效。因此，医疗保健专业人员和营养师越来越多地将这些专门的营养产品整合到整体糖尿病护理计划中，从而推动了市场需求。

整个产业分为产品、疾病类型、消费者、剂型、配销通路和地区。

从产品来看，肠外营养领域的糖尿病照护临床营养市场规模预计到 2032 年将产生可观的收入。肠外营养提供了一种细緻的营养管理方法，包括血糖管理解决方案，对于患有严重糖尿病或胃肠道挑战的个体尤其有益。

就剂型而言，液体领域的糖尿病护理临床营养市场预计将在2024 年至2032 年期间出现强劲的复合年增长率。方案专为糖尿病患者量身订做。代餐和治疗饮料等产品旨在提供均衡的营养和受调节的碳水化合物含量，有助于有效的血糖管理。

亚太地区糖尿病临床营养护理行业规模将在 2024 年至 2032 年间大幅增长。随着中国、印度和日本等国家的糖尿病发病率不断上升，对有效的临床营养解决方案的需求不断增加。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 糖尿病盛行率增加
    • 临床营养学的进展
    • 老年人口不断增加
  • 产业陷阱与挑战
    • 发展中经济体的认知有限
• 成长潜力分析
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

• 主要趋势
• 口服营养
  • 尚未准备好使用
  • 即用型
    • 液体
    • 固体
• 肠外营养
  • 常量营养素
    • 碳水化合物
    • 胺基酸
    • 脂质
  • 微量营养素
    • 维生素
    • 矿物质
• 肠内餵食配方
  • 标准成分
  • 疾病具体成分

第 6 章：市场估计与预测：按疾病类型，2021 - 2032 年

• 主要趋势
• 2型糖尿病
• 1 型糖尿病

第 7 章：市场估计与预测：按消费者分类，2021 - 2032 年

• 主要趋势
• 成人
• 儿科

第 8 章：市场估计与预测：按剂型，2021 - 2032

• 主要趋势
• 粉末
• 液体
• 坚硬的

第 9 章：市场估计与预测：按配销通路划分，2021 - 2032 年

• 主要趋势
• 零售药局
• 医院药房
• 网路药局
• 其他分销管道

第 10 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 11 章：公司简介

• Abbott Laboratories
• Baxter International Inc.
• B Braun Melsungen AG
• Danone Nutricia
• Dr Reddy's Laboratories Ltd.
• Mead Johnson and Company, LLC
• Nestle Health Science S.A.
• Nutrego
• Otsuka Holdings Co., Ltd.
• Pfizer Inc.
• Prohance
• Victus, Inc.

Clinical nutrition for diabetes care market size is set to record a 4.8% CAGR during 2024-2032 driven by the global rise in diabetes prevalence and the growing acknowledgment of the pivotal role of diets in managing the condition. As per WHO, around 422 million people have diabetes globally. Clinical nutrition products designed specifically for diabetes care, such as low glycemic index foods, fiber-rich supplements, and nutrient-enriched meal replacements, help manage blood glucose levels and improve overall health.

Advancements in product formulations and the creation of tailored nutritional plans, aligned with individual metabolic profiles and health conditions, are amplifying the efficacy of dietary interventions in diabetes management. As a result, healthcare professionals and dietitians are increasingly integrating these specialized nutrition products into holistic diabetes care plans, driving up market demand.

The overall industry is classified into product, disease type, consumer, dosage form, distribution channel, and region.

Based on product, the clinical nutrition for diabetes care market size from the parenteral nutrition segment is expected to generate notable revenue by 2032. This is due to its ability to provide crucial nutritional support for patients unable to meet dietary needs through oral means. Parenteral nutrition offers a meticulous approach to nutrient administration, including solutions for glucose management, especially beneficial for individuals grappling with severe diabetes or gastrointestinal challenges.

With respect to dosage form, the clinical nutrition for diabetes care market from the liquid segment is projected to observe a robust CAGR during 2024 - 2032. This growth is attributed to the convenience and digestibility of liquid nutritional solutions, which are specifically tailored for diabetic patients. Products like meal replacements and therapeutic beverages are crafted to deliver balanced nutrition with regulated carbohydrate content, aiding in effective blood glucose management.

Asia Pacific the clinical nutrition for diabetes care industry size will grow substantially between 2024 and 2032. This surge is linked to the region's rising diabetes prevalence, heightened healthcare awareness, and better access to specialized nutrition products. With countries like China, India, and Japan witnessing escalating diabetes rates, there is an amplified demand for effective clinical nutrition solutions.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of diabetes
    • 3.2.1.2 Advancements in clinical nutrition
    • 3.2.1.3 Growing geriatric population
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Limited awareness in developing economies
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Oral nutrition
  • 5.2.1 Not ready-to-use
  • 5.2.2 Ready-to-use
    • 5.2.2.1 Liquids
    • 5.2.2.2 Solids
• 5.3 Parenteral nutrition
  • 5.3.1 Macronutrients
    • 5.3.1.1 Carbohydrates
    • 5.3.1.2 Amino acids
    • 5.3.1.3 Lipids
  • 5.3.2 Micronutrients
    • 5.3.2.1 Vitamins
    • 5.3.2.2 Minerals
• 5.4 Enteral feeding formulas
  • 5.4.1 Standard composition
  • 5.4.2 Disease specific composition

Chapter 6 Market Estimates and Forecast, By Disease Type, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Type 2 diabetes
• 6.3 Type 1 diabetes

Chapter 7 Market Estimates and Forecast, By Consumer, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Adult
• 7.3 Pediatric

Chapter 8 Market Estimates and Forecast, By Dosage Form, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Powder
• 8.3 Liquid
• 8.4 Solid

Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 Retail pharmacies
• 9.3 Hospital pharmacies
• 9.4 Online pharmacies
• 9.5 Other distribution channels

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
  • 10.3.7 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
  • 10.4.6 Rest of Asia Pacific
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Rest of Latin America
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE
  • 10.6.4 Rest of Middle East and Africa

Chapter 11 Company Profiles

• 11.1 Abbott Laboratories
• 11.2 Baxter International Inc.
• 11.3 B Braun Melsungen AG
• 11.4 Danone Nutricia
• 11.5 Dr Reddy's Laboratories Ltd.
• 11.6 Mead Johnson and Company, LLC
• 11.7 Nestle Health Science S.A.
• 11.8 Nutrego
• 11.9 Otsuka Holdings Co., Ltd.
• 11.10 Pfizer Inc.
• 11.11 Prohance
• 11.12 Victus, Inc.